As a result, loss of RAD18 or UBC13 in BRCA1-deficient cancer cells does not abrogate reversed replication fork degradation, which is instead rescued upon knockdown of the fork reversal translocases SMARCAL1, ZRANB3 or HLTF. This evidence concerns the gene UBE2N and cancer.